ZURICH, Feb 27 (Reuters) – Medartis Holding AG, a medical device maker specializing in surgical bone repairs, plans to sell shares in an initial public offering (IPO) on the SIX Swiss Exchange in the first half of 2018, it said on Tuesday.
Medartis, whose products are sold in 44 countries, had sales of 105 million Swiss francs ($112 million) and operational EBITDA of 19 million in 2017.
“The planned IPO on the SIX Swiss Exchange will provide funds to finance Medartis’s growth and further raise its profile amongst surgeons and other stakeholders around the world,” it said in a statement.
Vischer AG is legal counsel to the issuer and Davis Polk is advising on U.S. securities law. Walder Wyss is advising the underwriters, while Quarton International is financial adviser to the company.